Mindways Software, Inc. Competitors

Nielsen NeuroFocus, a wholly-owned subsidiary of Nielsen, is the global leader in neurological testing for consumer research. With over 40 patents and a blue-chip client list representing Fortune 100 companies in dozens of categories, NeuroFocus® provides deep consumer insights into brands, products, packaging, in-store and retail marketing, and advertising.

At Synapse Software, we help organizations preserve and access critical service management data long after systems change. Our focus is simple: when you migrate from platforms like Cherwell, Ivanti Neurons, ServiceNow, or Jira Data Center, your historical data should remain fully accessible, usable, and secure—without the cost and complexity of keeping legacy systems alive. We work with IT teams, service providers, and enterprises navigating platform transitions, consolidations, or modernization initiatives. Instead of relying on static exports or read-only database backups, Cortex Archive provides structured, application-aware access to historical records—allowing teams to search, report, audit, and reference legacy data as if it were still live. Cortex Archive is purpose-built to support complex ITSM environments. With deep experience in Cherwell, Ivanti Neurons, ServiceNow, and Jira Data Center, we understand the data models, relationships, and compliance requirements that matter. That means faster implementations, cleaner archives, and more confidence when retiring production systems. Whether you're decommissioning on-prem infrastructure or simplifying your cloud footprint, Cortex Archive ensures your historical ITSM data remains accessible, compliant, and under your control—without unnecessary overhead. At Synapse Software, we believe retiring a system shouldn’t mean losing your data.

Neurotech.com is the central repository of market insights and analytics, and news for the NeuroTech space, including sectors, influencers, investors, technologies, R&D centers, Hubs, companies, and trends. Neurotech Industry is one of the most promising and perspective sectors of modern biotech in particular and exponential markets in general. Corporations, investors and other agents who will be able to utilize this growth and development will gain essential competitive advantages in their struggle for new markets, audiences, funding and technologies. Some of neurotech subsectors are already well-established, mature enough and can be seen as what may happen with the whole neurotech industry in the near future, whereas the others are emerging markets which consist of early-stage startups. Differentiation of the most perspective neurotech sectors is one of the most important goals for every player in the industry.